The Cell Engineering Division of RIKEN BioResource Center is a not-for-profit public "cell bank" that accepts donations and deposits of human and animal cell materials developed by the life science research community. We examine, standardize, amplify, preserve, and provide cell materials to scientists around the world. The major cell materials used around the world have been cultured cell lines, i.e., immortalized cells. Most human cell lines are derived from tumor cells. There is no doubt that the demand for these cell lines will never cease in the field of biology. In addition, stem cell lines such as embryonic stem (ES) cells and induced pluripotent stem (iPS) cells are of great value in current biology and medical science. Thus, we are extensively collecting such stem cell lines, aiming at contributing to the fields of developmental biology and transplantation/regenerative medicine. In addition, the demand for primary cells has recently increased. To meet this demand, we have started the banking of primary human cells including somatic stem cells, such as umbilical cord blood cells and cultured mesenchymal cells. The staff of the Cell Engineering Division conduct not only the banking of cell materials, but also research and development relating to cell materials, such as the establishment of novel human and animal-derived cell lines and the development of new technology to utilize cell materials.
Introduction

RIKEN
Cell Materials Available from RIKEN BRC
We possess more than two thousand immortalized cell lines (Table 1) , of which approximately 1,500 cell lines -ReviewReview Series: Animal Bioresource in Japan are immediately available for distribution. Approximately half of the cell lines were derived from humans (Table 2 ) and the other half of the cell lines were derived from various animals ( Table 1) .
Cell Materials Derived from Various Animals
We provide not only rodent cells but also cells derived from many other kinds of mammals (Table 1) . In addition to mammalian cells, we also provide other vertebrate cells such as bird-, amphibian-, and fish-derived cells. In relation to non-vertebrate cells, we provide insect cells as well. Many kinds of hybridoma cell lines, each of which produces a specific monoclonal antibody against a certain antigen, are also available.
Mouse Embryonic Stem (ES) Cell Lines
In addition to many kinds of mouse cell lines of somatic cell origin, we provide many kinds of mouse embryonic stem (ES) cell lines. Not only ES cell lines derived from the 129 strain but also ES cell lines derived from C57BL/6 strain are also available. In particular, two cell lines, B6G-2 (AES0003) [13] and BRC6 (AES0010) derived from C57BL/6N strain, have been confirmed to be differentiable into germ line cells. Thus, both B6G-2 and BRC6 can be used for the establishment of gene knock-out mouse strains with a C57BL/6N background.
We also provide many kinds of nuclear-transferred mouse ES cell lines [18] . Nuclear-transferred ES cell lines are established by reprogramming of somatic nuclei following their transfer into enucleated oocytes. Comparison of conventional ES cell lines with nuclear-transferred ES cell lines is potentially useful for studying the mechanism of reprogramming, and such comparisons may also contribute to understanding the mechanism underlying the establishment of induced pluripotent stem (iPS) cells. Please refer to the following website for more information on animal ES cell lines. http://www.brc.riken.jp/lab/cell/english/index_aes.shtml
Common Marmoset ES Cell Lines
We provide an ES cell line derived from the common marmoset, CMES40 (AES0053) [11] . It has recently been reported that a transgenic common marmoset was successfully established [12] . Hence, common marmoset ES cell lines will be very useful in the field of translational research, since it is likely that gene-modified common marmosets will be established using ES cell lines.
Cell Materials for Human Genome Research
To analyze the causes of certain specific diseases at the genomic level, many genome samples are required. However, it is not so easy to collect many samples at a time. Thus, the collection of many genome samples or cell lines containing the genome is very important and useful for researchers in the field.
We have collected two hundred Epstein-Barr virus (EBV)-transformed B cell lines derived from healthy Japanese people. Leukocyte antigen (HLA) haplotypes have been determined for half of them.
We are also collecting EBV-transformed B cell lines derived from cancer patients. At the moment, we possess 48 EBV-transformed B cell lines derived from breast cancer patients in Japan.
Goto Collection
This is a collection of cells derived from patients suffering from Werner syndrome [2] . Werner syndrome is characterized by the premature appearance of features associated with normal aging and cancer predisposition. Compared to progeria syndrome, another premature disease, Werner syndrome is characterized by late onset of symptoms. Of note, the majority of Werner syndrome patients in the world are Japanese. Thus, many scientists around the world are focusing on this collection.
Sonoda-Tajima Collection
Ancestors of Amerindians migrated from the Eurasian continent to North America continent via the Bering Strait, and then migrated to South America continent over 10 thousand years ago. Although human geneticists have tried to find their origin in Eurasia and to trace their migration paths with genetic methods, it has been difficult to obtain sufficient numbers of tissues or cell samples.
Dr. Sonoda who was a professor at Kagoshima University in Japan and Dr. Tajima, who is currently the director of Aichi Cancer Center Institute in Japan, spent nearly 30 years collecting peripheral blood samples from more than 3,500 individuals of Mongoloid minority groups around the world, mainly individuals living in South America (Fig. 1 ) [5] . Their cell collection was donated to the RIKEN BRC.
We are establishing EBV-transformed B cell lines from the donated peripheral blood samples. We have recently started a service to provide the EBV-transformed B cell lines together with information such as age, gender, tribe, and locality of the originating individual, and also relationships between specimen individuals.
Human Somatic Stem Cells
Compared with primary cells derived from experimental animals, human primary cells are very difficult to obtain. Current research in life sciences, however, requires human primary cells, such as stem cells, particularly in the fields of transplantation and regenerative medicine. We have succeeded in establishing systems for providing such human primary cells efficiently.
Umbilical cord blood is a source of hematopoietic stem cells as well as of other somatic stem cells. Human umbilical cord blood cells are readily available, but are usually discarded if they are not used in transplantation. Provided that the mother of a newborn baby agrees to allow the use of cord blood cells for research purposes, the material can be a valuable resource without the complicating factor of ethical concerns. By collaborating with the "Japanese Cord Blood Bank Network", we are supplying umbilical cord blood cells to domestic researchers in order to contribute to the fields of transplantation and regenerative medicine.
By collaborating with researchers in Japan who have developed technologies for expanding human mesenchymal stem cells in vitro very effi ciently [4, 17] , we are supplying human mesenchymal stem cells to domestic researchers. Mesenchymal stem cells can differentiate to bone, cartilage, muscle, tendon, cardiomyocytes, and so on. Thus, mesenchymal stem cells are very attractive and promising materials in the fi eld of regenerative medicine.
Human ES Cells
In April 2008, the Ministry of Education, Culture, Sports, Science and Technology of Japan approved the collection and distribution of human ES cell lines by RIKEN BRC. Human ES cell lines are very useful cell materials in many fi elds of biology such as developmental biology, regenerative medicine, and drug discovery. We have accepted the deposit of three human ES cell lines established at Kyoto University (KhES-1, KhES-2, KhES-3) [15] . From March 2009 we have been distributing KhES-1 and we anticipate distributing the other two human ES cell lines in the near future.
Induced Pluripotent Stem Cells
Dr. Yamanaka of Kyoto University (Japan) has developed a breakthrough technique in the fi eld of biology. He has enabled the induction of pluripotent stem cells (iPS cells) from somatic cells by using four defi ned factors. We have accepted the deposit of several iPS cell lines from Dr. Yamanaka: a mouse cell line established with four factors (Oct3/4, Sox2, Klf4, and c-myc in retrovirus vector) (Fig. 2) [8] , a mouse cell line established with three factors (Oct3/4, Sox2, and Klf4 in retrovirus vector) [7] , two mouse cell lines established with four factors (Oct3/4, Sox2, Klf4, and c-myc in plasmid vector) [9] , a human cell line established with four factors (Oct3/4, Sox2, Klf4, and c-myc in retrovirus vector) [16] , and a human cell line established with three factors (Oct3/4, Sox2, and Klf4 in retrovirus vector) [7] . We are currently providing all these iPS cell lines.
In the near future, the total number of iPS cell lines derived from patients (disease-specifi c iPS cells) will tremendously increase [10] . Accordingly, we plan to add them to our collection and provide such diseasespecifi c iPS cell lines as well. 
Quality Control of Cell Lines
Misidentifi cation of cell lines can result in the generation of erroneous scientifi c data [1, 14] . Hence, it is very important to eliminate cell lines whose origins differ from those claimed. Interspecies contamination can be detected by various established methods, such as karyotype and isozyme analyses. However, it has been impossible to detect intra-species cross-contamination in the absence of a technology for detecting differences between cell lines at the molecular level. Recently, the profi ling of short tandem repeat (STR) polymorphisms (STR profi ling) has been established as a method of analyzing gene polymorphism [6, 19] . STR profi ling is a simple and reliable method of identifying individual human cell lines. All human cell lines that are currently distributed from our division have been analyzed by STR profi ling to authenticate their identity. We found through such analysis that nearly 10% of the deposited cell lines had been misidentifi ed. STR profi ling is a useful and powerful method of eliminating cell lines that have been misidentifi ed as a result of cross-contamination or other causes, and STR profi ling of human cell lines is routinely performed in major cell banks around the world. If researchers would use only the cell lines that have been tested by STR profi ling in cell banks, misidentifi cation of human cell lines would be eradicated.
In relation to the cell lines derived from mice, we are performing simple sequence length polymorphism (SSLP) analysis, an analysis quite similar to STR profi ling on human cell lines, to confi rm mouse strain origins. Similar to human cell lines, nearly 10% of the deposited mouse cell lines were found to have been misidentifi ed by SSLP analysis. We have established a quality management system (QMS), and we are continuously performing all works in our laboratory according to this QMS. In July 2007 our QMS was accredited by ISO 9001, and the accreditation has been maintained (Fig. 3) .
Ethical Matters Relating to Human Cell Materials
The cell banking of human cells requires strict observation of ethical codes. We only accept human cell donations that are approved by the Institutional Review Board (IRB) at RIKEN Tsukuba Institute. Furthermore, RIKEN BRC contracts a Material Transfer Agreement (MTA) with the organization that deposits or donates human cells at RIKEN BRC. In the MTA, RIKEN BRC receives an assurance from the depositor that the human cell resources were obtained with appropriate informed consent. An approval by the IRB of the organization that deposits or donates human cells to RIKEN BRC is also necessary. When RIKEN BRC distributes human cells to users, we always contract a MTA with them. As for certain human cells, such as umbilical cord blood and mesenchymal stem cells, approval by the IRB of the user organization is also required.
Research and Development
Human and animal cell lines with multipotency or tissue-specifi c features are very useful for developmental biology and basic research in regenerative medicine. We are trying to establish such cell lines by various approaches. First, the identifi cation and purifi cation of tissue-specifi c somatic stem cells may lead to the establishment of such cell lines by immortalizing such somatic stem cells. Second, the induction of the differentiation of ES or iPS cells may lead to the establishment of such cell lines. In fact, we have recently succeeded in establishing erythroid cell lines from mouse ES cells (Fig. 4) [3] . We are investigating these possibilities using both human and animal cell materials.
All kinds of cells are affected by many factors, i.e., extracellular and intracellular factors, both in vivo and in vitro. Analyses of the functions of these factors are essential for improving cell culture and cell manipulation. The search for novel factors is also one of the most important research interests in this fi eld.
General Information of RIKEN Cell Bank
In recent years, more than four thousand ampoules have been distributed annually, mostly to not-for-profi t organizations (80%) and approximately 10% overseas. We will continue to accept deposits and donations of cultured human and animal cell lines and expand the collection, since the signifi cance of the cell lines in the field of biology will never cease. Japanese website of our division is as follows. http://www.brc.riken.jp/lab/cell/ English website of our division is as follows.
http://www.brc.riken.jp/lab/cell/english/ E-mail address for questions regarding materials and methods is as follows.
cellqa@brc.riken.jp E-mail address for questions regarding deposit and donation of cell lines is as follows.
cellbank@brc.riken.jp
